Correlation Between Broadcom and Tissue Regenix

Can any of the company-specific risk be diversified away by investing in both Broadcom and Tissue Regenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Broadcom and Tissue Regenix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Broadcom and Tissue Regenix Group, you can compare the effects of market volatilities on Broadcom and Tissue Regenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Broadcom with a short position of Tissue Regenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Broadcom and Tissue Regenix.

Diversification Opportunities for Broadcom and Tissue Regenix

0.69

Correlation Coefficient

Broadcom  Tissue Regenix

Poor diversification

The 3 months correlation between Broadcom and Tissue is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Broadcom and Tissue Regenix Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tissue Regenix Group and Broadcom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Broadcom are associated (or correlated) with Tissue Regenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tissue Regenix Group has no effect on the direction of Broadcom i.e., Broadcom and Tissue Regenix go up and down completely randomly.

Pair Corralation between Broadcom and Tissue Regenix

Assuming the 90 days trading horizon Broadcom is expected to generate 1.76 times more return on investment than Tissue Regenix. However, Broadcom is 1.76 times more volatile than Tissue Regenix Group. It trades about -0.08 of its potential returns per unit of risk. Tissue Regenix Group is currently generating about -0.36 per unit of risk. If you would invest  23,896  in Broadcom on December 24, 2024 and sell it today you would lose (4,867) from holding Broadcom or give up 20.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Broadcom  vs.  Tissue Regenix Group

Broadcom

Risk-Adjusted Performance

Very Weak

Over the last 90 days Broadcom has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Tissue Regenix Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tissue Regenix Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Broadcom and Tissue Regenix

The main advantage of trading using opposite Broadcom and Tissue Regenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Broadcom position performs unexpectedly, Tissue Regenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tissue Regenix will offset losses from the drop in Tissue Regenix's long position.

The idea behind Broadcom and Tissue Regenix Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.